|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Gritstone Oncology, Inc. (GRTS) |
|
|
$0.75 0.00 (-0.45%) as of 4:30 Thu 5/16
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
67,990,000 |
| Market
Cap: |
50.76(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.7366 - $2.9 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Gritstone bio is a biotechnology company developing targeted immunotherapies for cancer and infectious disease. Co. discovers, develops, manufactures, and delivers cancer and infectious disease immunotherapy candidates by utilizing both of its vaccine vectors, self-amplifying mRNA and chimpanzee adenovirus. Co.'s oncology programs in clinical stage development are GRANITE, an individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. Co.'s programs in clinical stage development are: CORAL, a second generation COVID-19 vaccine program and an HIV therapeutic/cure vaccine candidate that Co. is collaborating on with Gilead Sciences, Inc.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
12,000 |
12,000 |
| Total Buy Value |
$0 |
$0 |
$22,829 |
$22,829 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Yelensky Roman |
See Remarks |
• – – |
2021-01-19 |
4 |
S |
$22.10 |
$221,029 |
D/D |
(10,000) |
133,224 |
|
59% |
|
| Rousseau Raphael |
See Remarks |
• – – |
2021-01-19 |
4 |
AS |
$17.53 |
$350,564 |
D/D |
(20,000) |
0 |
|
-59% |
|
| Rousseau Raphael |
See Remarks |
• – – |
2021-01-19 |
4 |
OE |
$0.76 |
$15,200 |
D/D |
20,000 |
20,000 |
|
- |
|
| Yabannavar Vijay |
See Remarks |
• – – |
2021-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
31,696 |
|
- |
|
| Rousseau Raphael |
See Remarks |
• – – |
2021-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
29,700 |
29,700 |
|
- |
|
| Jooss Karin |
See Remarks |
• – – |
2021-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
27,900 |
349,784 |
|
- |
|
| Yelensky Roman |
See Remarks |
• – – |
2021-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
27,400 |
170,624 |
|
- |
|
| Hawryluk Matthew |
See Remarks |
• – – |
2021-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
19,600 |
24,198 |
|
- |
|
| Jones Erin |
See Remarks |
• – – |
2021-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
25,900 |
45,900 |
|
- |
|
| Thompson Rahsaan |
EVP and General Counsel |
• – – |
2021-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
25,500 |
29,487 |
|
- |
|
| Allen Andrew R |
President and CEO |
• • – |
2021-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
48,200 |
48,200 |
|
- |
|
| Jones Erin |
See Remarks |
• – – |
2020-08-17 |
4 |
OE |
$0.35 |
$3,450 |
D/D |
10,000 |
20,000 |
|
- |
|
| Rousseau Raphael |
See Remarks |
• – – |
2019-08-21 |
4 |
S |
$10.76 |
$107,631 |
D/D |
(10,000) |
0 |
|
- |
|
| Rousseau Raphael |
See Remarks |
• – – |
2019-08-21 |
4 |
OE |
$0.76 |
$7,600 |
D/D |
10,000 |
10,000 |
|
- |
|
| Jones Erin |
See Remarks |
• – – |
2019-01-29 |
4 |
OE |
$0.35 |
$3,450 |
D/D |
10,000 |
10,000 |
|
- |
|
| Green Jeremy |
10% Owner |
– – • |
2018-10-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,394,529 |
1,394,529 |
|
- |
|
| Versant Affiliates Fund V, L.p. |
general partner |
– – – |
2018-10-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,102,929 |
3,102,929 |
|
- |
|
| Simon Nicholas |
Director |
– • • |
2018-10-02 |
4 |
A |
$0.00 |
$0 |
I/I |
2,234,112 |
2,567,445 |
|
- |
|
| Clarus Ventures Iii, Llc |
General Partner |
– – – |
2018-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,234,112 |
2,567,445 |
|
- |
|
| Goeddel David V |
Managing Partner |
– – – |
2018-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,102,934 |
3,102,934 |
|
- |
|
| Svennilson Peter |
Director |
– • • |
2018-10-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,102,934 |
3,102,934 |
|
- |
|
| Woiwode Thomas |
Director |
– • • |
2018-10-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,102,929 |
3,102,929 |
|
- |
|
| Simon Nicholas |
Director |
– • • |
2018-09-28 |
4 |
B |
$15.00 |
$4,999,995 |
I/I |
333,333 |
333,333 |
2.25 |
- |
|
| Clarus Ventures Iii, Llc |
General Partner |
– – – |
2018-09-28 |
4 |
B |
$15.00 |
$4,999,995 |
D/D |
333,333 |
333,333 |
2.44 |
- |
|
74 Records found
|
|
Page 3 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
